Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study

Menopause

Volumn 22, Issue 10, 2015, Pages 1035-1044

  Sullivan, Shannon D ^a   Lehman, Amy ^b   Thomas, Fridtjof ^c   Johnson, Karen C ^c   Jackson, Rebecca ^d   Wactawski Wende, Jean ^e   Ko, Marcia ^f   Chen, Zhao ^g   Curb, J David ^h   Howard, Barbara V ⁱ  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h UNIVERSITY OF HAWAII   (United States)

ⁱ MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

Bone mineral density; Fracture; Menopause; Premature menopause

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; VITAMIN D;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; CALCIUM INTAKE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HIP FRACTURE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDY; OVARIECTOMY; PATIENT HISTORY OF HYSTERECTOMY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROSPECTIVE STUDY; RISK FACTOR; SALPINGOOOPHORECTOMY; SECONDARY ANALYSIS; SELF REPORT; SMOKING; SPINE; VITAMIN INTAKE; WOMEN'S HEALTH; AGE; CAUSALITY; ESTROGEN THERAPY; HIP FRACTURES; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES;

ADULT; AGE FACTORS; BONE DENSITY; CAUSALITY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HIP FRACTURES; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; WOMEN'S HEALTH;

EID: 84942510741     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000451     Document Type: Article

References (16)

1. Johnell O, Kanis JA, Odén A, et al. Mortality after osteoporotic fractures. Osteoporos Int 2004;15:38-42.
2. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999;353:878-882.
3. Tosteson AN, Gabriel SE, Grove MR, Moncur MM, Kneeland TS, Melton LJ III. Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 2001;12:1042-1049.
4. BlackDM, Steinbuch M, Palermo L, et al. Anassessment tool for predicting fracture in postmenopausal women. Osteoporos Int 2001;12:519- 528.
5. Sowers MR, Zhen H, Greendale GA, et al. Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab 2013;98:2854-2863.
6. Nguyen TV, Jones G, Sambrook PN, White CP, Kelly PJ, Eisman JA. Effect of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 1995; 80:2709-2714.
7. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001;19:3306-3311.
8. Castañeda S, Carmona L, Carvajal I, Arranz R, Díaz A, García-Vadillo A. Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 1997;60:343-347.
9. Bakalov VK, Chen ML, Baron J, et al. Bone mineral density and fractures in Turner syndrome. Am J Med 2003;115:259-264.
10. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606-614.
11. Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009;94: 2277- 2283.
12. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obset Gynecol 1998;9:12-15.
13. Popat VB, Calis KA, Kalantaridou SN, et al. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab 2014;99:3418-3426.
14. WHI Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
15. De Laet C, Odén A, Johansson H, Johnell O, Jönsson B, Kanis JA. The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 2005;16:313-318.
16. Prieto-Alhambra D, Premaor MO, Fina Avilés F, et al. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res 2012;27:294-300.